We aimed to avoid this bias when comparing cancer incidence in users of sulfonylurea, insulin, and other diabetes medications, respectively, with cancer incidence in metformin users. Research ...

Objective—Neonatal diabetes mellitus (NDM) can be caused by gain-of-function ATP-sensitive K + (K ATP) channel mutations. This realization has led to sulfonylurea therapy replacing insulin ...

Many people with type 2 diabetes can manage their blood sugar levels with lifestyle changes, including exercise and nutrition ...

Diabetes and heart health are closely connected. People with diabetes have a higher risk of heart failure, a condition where ...

Low blood sugar, or hypoglycemia, is a common challenge for people with diabetes. It happens when blood sugar levels drop ...

The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...

Managing diabetes involves daily blood sugar monitoring, specialized devices, and medications like insulin, so understanding ...

Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar, works. A study provided direct evidence in mice that it ...

The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals) ...

Nesina, Kazano, and Oseni were studied as stand-alone therapies (monotherapies) and in combination with other type 2 diabetes therapies, including sulfonylureas and insulin. Nesina was ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...